Trial on Far Infrared Rays and TENS for Head and Neck Cancer Patients
A clinical trial is evaluating the efficacy of far infrared radiation therapy and transcutaneous electrical nerve stimulation in reducing side effects for head and neck cancer patients undergoing chemoradiotherapy.
Phase III
head and neck cancer patients
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The ongoing clinical trial on far infrared rays and TENS for head and neck cancer patients could significantly influence treatment protocols in oncology by potentially integrating these adjunct therapies into standard care. Positive outcomes may enhance patient comfort and reduce side effects, thereby improving overall treatment efficacy.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results and any changes in treatment guidelines based on the outcomes of this study.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.